Compounds > buthionine sulfoximine
Page last updated: 2024-08-22

buthionine sulfoximine and Stomach Neoplasms

buthionine sulfoximine has been researched along with Stomach Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lohn, JW; Seifalian, AM; Toffa, SE; Winslet, MC; Yang, W1
Furukawa, T; Ishibiki, K; Kitajima, M; Kubota, T; Kuo, TH; Saikawa, Y; Tanino, H; Watanabe, M1
Guo, J; Hu, X; Pal, A; Singh, SV; Srivastava, SK; Xia, H1
Hong, YS; Kang, JH; Kim, DJ; Kim, HK; Lee, KS; Moon, HS; Park, JG1
Cai, RM; Ding, L; Jin, XQ; Jin, YZ; Lu, WQ; Shen, ZF; Xu, JF; Xu, LM; Yang, JK1
Barranco, SC; Beasley, EG; Liu, NH; MacLean, KK; Schellenberg, K; Shaeffer, J; Townsend, CM; Weintraub, B1

Other Studies

6 other study(ies) available for buthionine sulfoximine and Stomach Neoplasms

ArticleYear
Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
    Gynecologic oncology, 2005, Volume: 96, Issue:2

    Topics: Adenocarcinoma; Antioxidants; Ascites; Blotting, Northern; Buthionine Sulfoximine; Cell Adhesion; Cell Line, Tumor; Cell Survival; Female; Gene Expression; Glutathione; Humans; Hyaluronan Receptors; Lipid Peroxidation; Malondialdehyde; Ovarian Neoplasms; Oxidative Stress; Stomach Neoplasms

2005
Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
    Japanese journal of cancer research : Gann, 1993, Volume: 84, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; Humans; Male; Methionine Sulfoximine; Mice; Mice, Inbred BALB C; Mice, Nude; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

1993
Potentiation of benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis in mice by D,L-buthionine-S,R-sulfoximine-mediated tissue glutathione depletion.
    Cancer letters, 2000, May-29, Volume: 153, Issue:1-2

    Topics: Animals; Antimetabolites; Benzo(a)pyrene; Buthionine Sulfoximine; Carcinogens; Drug Synergism; Female; Glutathione; Lung Neoplasms; Mice; Stomach Neoplasms

2000
Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
    The Korean journal of internal medicine, 1992, Volume: 7, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Female; Glutathione; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Stomach Neoplasms; Tumor Cells, Cultured

1992
Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Chinese medical journal, 1992, Volume: 105, Issue:8

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Hypoxia; Cisplatin; Drug Synergism; Fluorouracil; Glutathione; Humans; Leukemia, Erythroblastic, Acute; Methionine Sulfoximine; Misonidazole; Stomach Neoplasms; Tumor Cells, Cultured

1992
Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
    Cancer research, 1990, Jun-15, Volume: 50, Issue:12

    Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Drug Screening Assays, Antitumor; Glutathione; Humans; Melphalan; Methionine Sulfoximine; Stomach Neoplasms; Time Factors; Tumor Cells, Cultured

1990